FDA approves Takeda’s Mimrylo for polycythemia vera
FDA has approved Takeda’s Mimrylo for the rare blood disorder polycythemia vera.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.